Independent Portfolio Consultants’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.29M Buy
18,230
+9,173
+101% +$610K 0.54% 32
2017
Q1
$615K Sell
9,057
-4,463
-33% -$314K 0.21% 165
2016
Q4
$968K Sell
13,520
-1,936
-13% -$144K 0.32% 96
2016
Q3
$1.22M Buy
15,456
+368
+2% +$29.9K 0.38% 63
2016
Q2
$1.26M Sell
15,088
-6,680
-31% -$593K 0.4% 59
2016
Q1
$2M Buy
21,768
+785
+4% +$70.8K 0.56% 31
2015
Q4
$2.12M Sell
20,983
-7,420
-26% -$772K 0.63% 24
2015
Q3
$2.79M Buy
28,403
+7,214
+34% +$801K 0.61% 31
2015
Q2
$2.48M Buy
21,189
+376
+2% +$41.1K 0.5% 52
2015
Q1
$2.04M Buy
20,813
+717
+4% +$72.8K 0.42% 77
2014
Q4
$1.89M Buy
20,096
+19,923
+11,516% +$2.06M 0.38% 87
2014
Q3
$18K Sell
173
-992
-85% -$97.1K ﹤0.01% 704
2014
Q2
$97K Buy
+1,165
New +$90.7K 0.03% 529
2014
Q1
Sell
-8,691
Closed -$653K 463
2013
Q4
$653K Sell
8,691
-10,871
-56% -$757K 0.23% 145
2013
Q3
$1.23M Buy
19,562
+319
+2% +$19.1K 0.49% 30
2013
Q2
$987K Buy
+19,243
New +$1M 0.44% 36

Other funds holding GILD

Independent Portfolio Consultants's GILD Position: Q2 2017 in Review

Independent Portfolio Consultants increased its Gilead Sciences (GILD) stake by 101% in Q2 2017, buying an estimated $610K and bringing the position to 18,230 shares worth $1.29M. The position accounts for 0.54% of the portfolio, ranked #32.

Independent Portfolio Consultants first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $2.79M in Q3 2015. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Independent Portfolio Consultants held 18,230 shares of Gilead Sciences worth $1.29M as of Q2 2017.
  • Independent Portfolio Consultants bought 9,173 Gilead Sciences shares in Q2 2017, an estimated $610K.
  • Gilead Sciences made up 0.54% of Independent Portfolio Consultants's portfolio in Q2 2017, its #32 holding.
  • Independent Portfolio Consultants first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
  • Independent Portfolio Consultants's Gilead Sciences position peaked at $2.79M in Q3 2015.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.